


We believe that food allergies should not get in the way of making every moment in our lives count. #makeeverymomentcount🧡


📚 We have another education seminar in store in June! Javier Evelyn, founder/CEO of Alerje, will discuss lessons learned on his founder journey from startup to acquisition. 🗓️ Weds, 6/17 ⏰ 2-3pm CT 🔗 ow.ly/Y3nQ50Z6LAO #MedTech #Innovation #Pediatrics #CTIP


Sempresto acquires Alerje’s smartphone-mounted auto-injector platform — strengthening its lead in mobile drug delivery tech. Alerje now shifts to AI-powered food allergy tools. Full story: hubs.li/Q03WWNf60 #MedicalEconomics #MedTech #DigitalHealth #SmartphoneHealth

Amazing 👏🏼 Bravo to @alerje Sempresto Acquires Alerje’s Autoinjector Platform to Accelerate Commercialization of Smartphone Integrated Rescue Medications - businesswire.com/news/home/2…

We're proud to support @alerje, one of our portfolio companies, as they enter a new chapter focused on improving outcomes for food allergy families. Excited to see what's next for them!
We've completed the sale of the OmniJect device to SemPresto! This honors the work behind the device and places it with a world class team to take it forward. Our mission remains the same, focusing on collaborative, connected food allergy care! businesswire.com/news/home/2…

Sempresto Acquires Alerje’s Autoinjector Platform to Accelerate Commercialization of Smartphone Integrated Rescue Medications dlvr.it/TPdHzH

We've completed the sale of the OmniJect device to SemPresto! This honors the work behind the device and places it with a world class team to take it forward. Our mission remains the same, focusing on collaborative, connected food allergy care! businesswire.com/news/home/2…

We had a great time at this year’s @ACAAI, connecting with new and familiar faces across the allergy and immunology community. Always inspiring to hear about the latest innovations and see how aligned we all are. Excited for what’s ahead! #ACAAI2025

Alerje has officially received its 14th issued patent, our 1st software based IP! US 12380979, covers our integrated system for food allergy immunotherapy monitoring combining connected devices, physician dashboards, and personalized treatments 🥜🧪📱


We’re teaming up with @Nickelodeon & @paramountco to raise awareness about food allergies—impacting 1 in 13 kids. 💥 Watch Emmy-winning #TinyChefShow and #MerrickHanna in our new PSA! 🎥 Learn more at foodallergyfund.org. #FoodAllergyAwareness #FoodAllergyFund

As we continues to advance our food allergy care platform, we're excited to announce two key additions to our leadership team! They enhance our clinical expertise and regulatory capabilities at a pivotal moment in our company's growth journey. 🚀 linkedin.com/pulse/strategic…

We’re excited to share that Alerje has reached another global milestone! 🌍 Our epinephrine auto-injector phone case just earned a patent in Japan 🇯🇵, expanding access to fast, reliable emergency care. As food allergies rise, we’re committed to supporting those who need it most.

Innovation is a team effort! Big shoutout to our engineers & designers for helping secure another U.S. patent for Alerje. Our epinephrine auto-injector phone case makes emergency allergy care more accessible than ever. Onward! 🧡🚀

We are so excited for the amazing children book, Author by EAF Co-founder Thomas Silvera. elijahalavifoundation.org/po… #foodallergy #asthma #foodallergies #foodallergyawareness #publishing #childrenbook #bookspotlight #comicbook #elijahsecho